You are here

  • Home
  • Archive
  • Volume 22, Issue 1
  • Intravenous/Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma: A Feasibility Study

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Intravenous/Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma: A Feasibility Study

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 20192400
Apr 20193000
May 20194100
Jun 20192600
Jul 20192902
Aug 20193602
Sep 20192000
Oct 20192000
Nov 20194000
Dec 20193200
Jan 20202000
Feb 20203800
Mar 20203200
Apr 20201002
May 20202200
Jun 20206200
Jul 20202200
Aug 20203201
Sep 20203402
Oct 20201600
Nov 20201804
Dec 2020800
Jan 20212700
Feb 20213103
Mar 20211001
Apr 20211000
May 2021302
Jul 2021001
Aug 2021002
Oct 20211201
Nov 20211200
Dec 20211000
Jan 20222000
Feb 20222400
Mar 20226401
Apr 20222500
May 20224200
Jun 20223800
Jul 20222400
Aug 20224200
Sep 20224402
Oct 20225600
Nov 20221200
Dec 20221200
Jan 20231200
Feb 20235400
Mar 20232400
Apr 2023400
May 2023800
Jun 20231100
Jul 20231200
Aug 20231200
Sep 20231400
Oct 20235901
Nov 20232000
Dec 20233800
Jan 20242600
Feb 20241600
Mar 2024601
Apr 20241400
Total1460028